Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-naïve diffuse large B-cell lymphoma.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis study was approved by the Institutional Review Board of Taipei Veterans General Hospital (no. 2019-04-015CC, 2020-07-024BCF and 2022-01-031CC), and written informed consent was obtained from each enrolled patient with respect to the use of their blood for scientific purposes. Consent for publicationConsent for publication was obtained from the patient. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This study was supported by grants from the Ministry of Science and Technology (MOST 108-2314-B-075-070-MY3), Taipei Veterans General Hospital (V110B-012), and the Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang Ming Chiao Tung University. Funding"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025